ÂÜÀòÂÒÂ×

Valerie Cullen is an accomplished pharmaceutical and biotechnology executive with extensive experience in research and translational science. Currently serving as the Senior Vice President and Head of Research and Translational Science at Lysoway Therapeutics since May 2024, Cullen previously held key leadership roles at Expansion Therapeutics, Generian, Lysosomal Therapeutics Inc, Aldeyra Therapeutics, and Proclara Biosciences, among others. Notable achievements include leading research efforts across multiple sites, overseeing drug development programs, and playing crucial roles in fundraising and scientific strategy. Cullen's educational background boasts a PhD in Pharmacology, extensive postdoctoral training in Neuroscience and Neuropharmacology from prestigious institutions such as Harvard Medical School and King's College London.